- Report
- October 2024
- 182 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- October 2024
- 130 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- July 2024
- 120 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- December 2024
- 200 Pages
Global
From €3560EUR$3,750USD£3,003GBP
- Report
- February 2025
- 183 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- September 2023
- 200 Pages
Global
From €2326EUR$2,450USD£1,962GBP
High Potency API Contract Manufacturing is a specialized form of pharmaceutical manufacturing that involves the production of active pharmaceutical ingredients (APIs) with high levels of potency. These APIs are typically used in the production of drugs that require a high degree of safety and efficacy, such as cancer treatments and other complex drugs. The process of high potency API contract manufacturing involves the use of specialized equipment and processes to ensure the highest levels of safety and quality. This includes the use of containment systems, specialized cleaning and sterilization processes, and the use of advanced analytical techniques.
High Potency API Contract Manufacturing is a rapidly growing market, driven by the increasing demand for complex drugs and the need for specialized manufacturing processes. Companies in this market include Lonza, Boehringer Ingelheim, Patheon, and Recipharm. Show Less Read more